NaCTeM to support the development of innovative pathology tests
2015-07-27
NaCTeM will form part of the University of Manchester team in a new set of projects whose aim is to bring innovative pathology tests to patients. A total of six projects is being supported by the MRC and EPSRC, led by different universities in the UK, with collaboration from clinicians and industry.
The University of Manchester node (Manchester Molecular Pathology Innovation Centre) has been awarded funding of £2.9. The node will focus on developing biomarker based molecular pathology tests, with the initial work aimed at creating tests to diagnose, pick the right treatment and asses the response to treatment for a range of inflammatory conditions including rheumatoid arthritis, lupus and psoriasis.
NaCTeM will provide text mining solutions to support this work. Prof. Sophia Ananiadou is a co-investigator on the project and a dedicated Research Associate will be employed to work on the text mining research for 4 years.
More information...
http://www.mrc.ac.uk/news-events/news/six-major-projects-to-bring-innovative-pathology-tests-to-patients/
Previous item | Next item |
Back to news summary page |
Featured News
- Congratulations to PhD student Panagiotis Georgiades
- 24-month postdoctoral research position in Athens, Greece
- PhD opportunity in collaboration with Athens Univ. of Economics and Business
- iCASE EPSRC funded PhD- multimodal NLP - UoM & BAE - Application deadline 30th April 2024
- CFP: BIONLP 2024 and Shared Tasks @ ACL 2024
- Advances in Data Science and Artificial Intelligence Conference 2024
Other News & Events
- Invited talk at the 8th Annual Women in Data Science Event at the American University of Beirut
- Invited talk at the 2nd Symposium on NLP for Social Good (NSG), University of Liverpool
- Invited talk at Annual Meeting of the Danish Society of Occupational and Environmental Medicine
- New review article on emotion detection for misinformation
- BioNLP 2024 accepted as workshop at ACL 2024